PDK1 and cancer: Collectively, these data suggest that MAPK4 both PDK1-independently and -dependently regulates tumor cell response to PI3K blockade, and MAPK4 overexpression renders cancer cells at least partially resistant to PI3K and PDK1 co-blockade.